3/2
08:00 am
naut
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Low
Report
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
2/27
10:58 am
naut
Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.
Low
Report
Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.
2/26
05:59 pm
naut
Nautilus Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Nautilus Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
08:00 am
naut
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
High
Report
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
2/24
08:00 am
naut
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
Low
Report
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
2/19
04:44 pm
naut
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/19
04:05 pm
naut
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
2/5
09:27 am
naut
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
Low
Report
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
2/5
08:00 am
naut
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Medium
Report
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
1/28
08:00 am
naut
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
Medium
Report
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
1/8
08:00 am
naut
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
Low
Report
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
12/29
07:47 am
naut
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) boasts of bullish insider sentiment with 33% ownership and they have been buying lately [Yahoo! Finance]
Low
Report
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) boasts of bullish insider sentiment with 33% ownership and they have been buying lately [Yahoo! Finance]